Utilization of the ketogenic diet for adults with status epilepticus
•Significant heterogeneity exists in the current practices employing ketogenic diet as treatment modality for status epilepticus.•Barriers identified for low rate of utilization of ketogenic diet for status epilepticus by healthcare providers include anticipated difficulty achieving ketosis, lack of...
Gespeichert in:
Veröffentlicht in: | Epilepsy & behavior 2023-07, Vol.144, p.109279-109279, Article 109279 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Significant heterogeneity exists in the current practices employing ketogenic diet as treatment modality for status epilepticus.•Barriers identified for low rate of utilization of ketogenic diet for status epilepticus by healthcare providers include anticipated difficulty achieving ketosis, lack of expertise, lack of resources, and lack of dietitian support.•Randomized clinical trials supporting efficacy of ketogenic diet for status epilepticus could be instrumental in increased use of ketogenic diet by healthcare providers.
The ketogenic diet (KD) is a high-fat, low-carbohydrate diet with therapeutic potential in refractory seizures, both in outpatient and inpatient settings. Successful implementation of KD involves a multifaceted, interdisciplinary approach to address anticipated challenges. We sought to characterize the utilization of KD among healthcare providers caring for adults with status epilepticus (SE).
We distributed a web-based survey through professional societies, including the American Academy of Neurology (AAN), Neurocritical Care Society (NCS), American Epilepsy Society (AES), Neuro Anesthesia and Critical Care Society (NACCS), and the Academy of Nutrition and Dietetics (AND), and via research contacts. We asked respondents about practice experience and experience using KD as a treatment for SE. Descriptive statistics and Chi-square tests were used to analyze the results.
Of 156 respondents, 80% of physicians and 18% of non-physicians reported experience with KD for SE. Anticipated difficulty in achieving ketosis (36.3%), lack of expertise (24.2%), and lack of resources (20.9%) were identified as the most important barriers limiting the utilization of KD. The absence of dietitians (37.1%) or pharmacists (25.7%) support was the most important missing resource. Reasons for stopping KD included perceived ineffectiveness (29.1%), difficulty achieving ketosis (24.6%), and side effects (17.3%). Academic centers had more experience with the use of KD and greater EEG monitoring availability and fewer barriers to its implementation. The need for randomized clinical trials supporting efficacy (36.5%) and better practice guidelines for implementation and maintenance of KD (29.6%) were cited most frequently as factors to increase utilization of KD.
This study identifies important barriers to the utilization of KD as a treatment for SE despite evidence supporting its efficacy in the appropriate clinical context, namely lack of resources and interdisc |
---|---|
ISSN: | 1525-5050 1525-5069 |
DOI: | 10.1016/j.yebeh.2023.109279 |